M ml Mo a Hu Epithelial Membrane Antigen, Clone E29 M ,2 ml Mo a Hu Epithelial Membrane Antigen, Clone E29 M ml Mo a Hu
|
|
|
- Clarence Williams
- 7 years ago
- Views:
Transcription
1 M ml Mo a Hu Epithelial Membrane Antigen, Clone E29 M ,2 ml Mo a Hu Epithelial Membrane Antigen, Clone E29 M ml Mo a Hu Von Willebrand Factor, Clone F8/86 M ml Mo a Thrombomodulin, Clone 1009 M ml Mo a Hu Cytokeratin, High Molecular Weight, Clone 34ßE12 M ,2 ml Mo a Hu Cytokeratin, High Molecular Weight, Clone 34ßE12 M ml Mo a Rb Macrophage, Clone RAM11 M ml Mo a Hu Melanosome, Clone HMB-45 M ,2 ml Mo a Hu Melanosome, Clone HMB-45, 0.2 ml M ml Mo a Hu Muscle Actin, Clone HHF35 M ml Mo a Hu Laminin, Clone 4C7 M ml Mo a Metallothionein, Clone E9 M ml Mo a Hu CD45, Leucocyte Common Antigen, Clones 2B11 + PD7/26 M ,2 ml Mo a Hu CD45, Leucocyte Common Antigen, Clones 2B11 + PD7/26 M ml Mo a Hu CD68, Macrophage, Clone EBM11 M ml Mo a Vimentin, Clone V9 M ,2 ml Mo Anti-Vimentin, Clone V9 M ml Mo a Hu HLA-ABC Antigen, Clone W6/32 M ml Mo a Rb Immunoglobulins, Clone MR12/53 M ml Mo a Hu CD45R0, Clone UCHL1 M ml Mo a Bromodeoxyuridine, Clone Bu20a M ml Mo a Hu HLA-DR Antigen, Alpha-Chain, Clone TAL.1B5 M ml Mo a Hu Myeloid/Histiocyte Antigen, Clone MAC 387 M ,2 ml Mo a Hu Prostate-Specific Antigen, Clone ER-PR8 M ml Mo a Hu CD30, Clone Ber-H2 M ,2 ml Mo a Hu CD30, Clone Ber-H2 M ml Mo a Hu Neutrophil Elastase, Clone NP57 M ml Mo a Hu CD61, Platelet Glycoprotein IIIa, Clone Y2/51 M ml Mo a Hu CD45RA, Clone 4KB5 M ml Mo a Hu CD20cy, Clone L26 M ,2 ml Mo a Hu CD20cy, B Cell, Clone L26 M ml Mo a Human Serotonin, Clone 5HT-H209 M ml Mo a Hu Amyloid A, Clone mc1 M ml Mo a Hu Desmin, Clone D33 M ,2 ml Mo a Hu Desmin, Clone D33 M ml Mo a Hu Glial Fibrillary Acidic Protein, Clone 6F2 M ,2 ml Mo a Hu Neurofilament Protein, Clone 2F11 M ml Mo a Hu CD23, Clone MHM6 M ,2 ml Mo a Hu CD23, Clone MHM6 M ml Mo a Hu HLA-DP, DQ, DR Antigen, Clone CR3/43 M ml Mo a Hu C5b-9, Clone ae11 M ml Monoclonal Mo a Pneumocystis Jiroveci, Clone 3F6 M ml Mo a Hu Thyroglobulin, Clone DAK-Tg6 M ml Mo a Hu CD21, Clone 1F8 M ,2 ml Mo a Hu CD21, Clone 1F8 M ml Mo a Hu Collagen IV, Clone CIV 22 M ml Mo a Hu CD43, Clone DF-T1 M ml Mo a Hu Prostatic Acid Phosphatase, Clone PASE/4LJ M ml Mo a Hu Epithelial Antigen, Clone Ber-EP4 M ,2 ml Mo a Hu Epithelial Antigen, Clone Ber-EP4
2 M ml Mo a Hu CD68, Clone KP1 M ml Mo a Hu CD235a, Glycophorin A, Clone JC159 M ml Mo a Hu Glycophorin C, Clone Ret40f M ml Mo a Hu Cytokeratin, Clone MNF116 M ml Mo a Hu CD31, Endothelial Cell, Clone JC70A M ,2 ml Mo a Hu CD31, Endothelial Cell, Clone JC70A M ml Mo a Hu CD14, Clone TÜK4 M ml Mo a Hu CD35,Clone Ber-MAC-DRC M ml Mo a Hu Smooth Muscle Actin, Clone 1A4 M ,2 ml Mo a Hu Smooth Muscle Actin, Clone 1A4 M ml Mo a Cytomegalovirus, Clones CCH2 + DDG9 M ml Mo a Hu Immunodeficiency Virus, p24, Clone Kal-1 M ml Mo a Hu Chromogranin A, Clone DAK-A3 M ,2 ml Mo a Hu Chromogranin A, Clone DAK-A3 M ml Mo a Hu Beta-Amyloid, Clone 6F/3D M ml Mo a Hu Neuron-Specific Enolase, Clone BBS/NC/VI-H14 M ,2 ml Mo a Hu Neuron-Specific Enolase, Clone BBS/NC/VI-H14 M ml Mo a Sarcomeric Actin, Clone Alpha-Sr-1 M ml Mo a Hu CD68, Clone PG-M1 M ,2 ml Mo a Hu CD68, Macrophage, Clone PG-M1 M ml Mo a Proliferating Cell Nuclear Antigen, Clone PC10 M ml Mo a Hu Leukaemia, Hairy Cell, Clone DBA.44 M ml Mo a Hu BCL2 Oncoprotein, Clone 124 M ,2 ml Mo a Hu BCL2 Oncoprotein, Clone 124 M ml Mo a Hu Cytokeratin 19, Clone RCK108 M ml Mo a Epstein-Barr Virus, LMP, Clones CS 1-4 M ml Mo a Adrenocorticotropin (ACTH), Clone 02A3 M ml Monoclonal Mouse Ant-Human Luteinizing Hormone (LH) M ml Monoclonal Mouse Anti-Human Thyroid Stimulating Hormone (TSH) M ml Monoclonal MxH Follicle Stimulating Hormone (FSH) Clone C10 M ml Mo a Hu Mesothelial Cell, Clone HBME-1 M ml Mo a Hu MyoD1, Clone 5.8A M ml Mo a Hu Cytokeratin, Clone AE1/AE3 M ,2 ml Mo a Hu Cytokeratin, Clone AE1/AE3, 0.2 ml M ml Mo a CA 19-9, Clone 116-NS-19-9 M ml Mo a Hu CA 125, Clone M11 M ml Mo a Hu Epithelial-Related Antigen, Clone MOC-31 M ml Mo a Hu CD105, Endoglin, Clone SN6h M ml Mo a Hu Papillomavirus (HPV), Clone K1H8 M ml Monoclonal Mo a Hu β-catenin, Clone β-catenin-1, 1 ml M ml Mo a Hu Calponin, Clone CALP M ml Mo a Hu Caldesmon, Clone h-cd M ml Mo a Hu Smooth Muscle Myosin Heavy Chain, Clone SMMS-1 M ml Mo a Myogenin, Clone F5D M ml Mo a Hu Wilms' Tumour 1 (WT1) Protein, Clone 6F-H2 M ml Mo a Hu Androgen Receptor, Clone AR441 M ml Mo a Hu Epidermal Growth Factor Receptor, Clone H11 M ml Monoclonal MxH Fascin, Clone 55K-2 M ml Mo a Hu Progesterone Receptor, Clone PgR 636 M ,2 ml Mo a Hu Progesterone Receptor, Clone PgR 636, 0.2 ml
3 M ml Mo a Hu CD1a, 010 M ml Mo a Thyroid Transcription Factor, TTF-1, Clone 8G7G3/1 M ,2 ml Mo a Thyroid Transcription Factor, TTF-1, Clone 8G7G3/1, 0.2 ml M ml Mo a Hu CD99, MIC2 Gene Products, Ewing's Sarcoma Marker, Clone 12E7 M ml BRCA1 MAb MxH GLK2 M ml Mo a Hu Inhibin α, Clone R1 M ml Mo a Hu E-Cadherin, Clone NCH-38 M ,2 ml Monoclonal MxH E-Cadherin NCH-38 M ml Mo a Hu N-Cadherin, Clone 6G11 M ml Mo a Hu Thymidylate Synthase, Clone TS106 M ml Monoclonal Mo a Hu Prostein, Clone 10E3 M ,2 ml Monoclonal Mo a Hu Prostein, Clone 10E3 M ml Monoclonal Rb a Hu AMACR, Clone 13H4 M ,2 ml Monoclonal Rb a Hu AMACR, Clone 13H4 0.2 ml M ml Mo a Hu COX-2, Clone CX-294 M ml Mo a Hu D2-40, Clone D2-40 M ,2 ml Mo a Hu D2-40, Clone D2-40 M ml Monoclonal Mo a Hu Prostate-Specific Membrane Antigen, Clone 3E6 M ,2 ml Monoclonal Mo a Hu Prostate-Specific Membrane Antigen, Clone 3E6 M ,2 ml MAb MxH MITF D5 M ,2 ml Monoclonal Mo a Hu Tyrosinase, Clone T311 M ,2 ml Monoclonal Mo a Hu Survivin, Clone 12C4 M ,2 ml Monoclonal Mo a Hu Mammaglobin Clone 304-1A5 0.2mL M ,2 ml Monoclonal Mo a Hu IMP3, Clone 69.1 M ,2 ml PTEN 0.2mL MAb MxH M ml Monoclonal RxH Akt ps473 Clone 14-5 M ml Monoclonal RxH p53 Clone M ,2 ml Monoclonal RxH p53 Clone M ml Monoclonal MxH CD15 Clone Carb-3 M ,2 ml Monoclonal MxH CD15 Clone Carb-3 M ml Monoclonal MxH Renal Cell Carcinoma Clone SPM314 M ,2 ml Monoclonal MxH Renal Cell Carcinoma Clone SPM314 M ml Monoclonal Mouse anti-human CDX2, Clone DAK-CDX2 M ,2 ml Monoclonal Mouse anti-human CDX2, Clone DAK-CDX2 M ml Monoclonal Mx Villin Clone 1D2 C3 M ,2 ml Monoclonal Mx Villin Clone 1D2 C3 M ml Monoclonal Mo X-Human Gross Cystic Disease Fluid Protein-15 Clone 23A3 M ,2 ml Monoclonal Mo X-Human Gross Cystic Disease Fluid Protein-15 Clone 23A3 M ml Monoclonal Mo a Hu MSH2, Clone FE11 M ,2 ml Monoclonal Mo a Hu MSH2, Clone FE11 M ml Monoclonal Mo X-Human MutL Protein Homolog 1, Clone ES05 M ,2 ml Monoclonal Mouse anti-human MutL Protein Homolog 1, Clone ES05 M ml Monoclonal Mouse anti-human CD5, Clone 4C7 M ,2 ml Monoclonal Mouse Anti-Human CD5, Clone 4C7 M ml Monoclonal Rabbit anti-human Cyclin D1, Clone EP12 M ,2 ml Monoclonal Rabbit anti-human Cyclin D1, Clone EP12 M ml Monoclonal Rabbit anti-human ER alpha, Clone EP1 M ,2 ml Monoclonal Rabbit Anti-Human ER alpha, Clone EP1 M ml Monoclonal Rb a Hu MSH6, Clone EP49 M ,2 ml Monoclonal Rb a Hu MSH6, Clone EP49
4 M ml Monoclonal Rb a Hu PMS2 Clone EP51 M ,2 ml Monoclonal Rb a Hu PMS2, Clone EP51 M ml Monoclonal Mo a Hu ERCC-1, Clone 4F9 M ,2 ml Monoclonal Mo a Hu ERCC-1, Clone 4F9 M ml Monoclonal Mo a Hu OCT3/4, Clone N1NK M ,2 ml Monoclonal Mo a Hu OCT3/4, Clone N1NK M ml Monoclonal Rb a Hu TdT, Clone EP266 M ml Monoclonal Rb a Hu CK8/18, Clone EP17/30 M ml Mo a Hu p53 Protein, Clone DO-7 M ,2 ml Mo a Hu p53 Protein, Clone DO-7 M ml Mo a Hu Cytokeratin 10, Clone DE-K10 M ml Mo a Hu Cytokeratin 10/13, Clone DE-K13 M ,2 ml Mo a Hu Cytokeratin 18, Clone DC 10 M ml Mo a Hu Cytokeratin 7, Clone OV-TL 12/30 M ,2 ml Mo a Hu Cytokeratin 7, Clone OV-TL 12/30 M ml Mo a Hu Cytokeratin 20, Clone Ks20.8 M ,2 ml Mo a Hu Cytokeratin 20, Clone Ks20.8 M ml Mo a Vimentin, Clone Vim 3B4 M ml Mo a Cytokeratin 17, Clone E3 M ml Mo a Hu Estrogen Receptor α, Clone 1D5 M ,2 ml Mo a Hu Estrogen-Receptor α, 1D5 M ml Mo a Hu CD79α, Clone JCB117 M ,2 ml Mo a Hu CD79α, Clone JCB117 M ,2 ml Mo a Hu Mast Cell Tryptase, Clone AA1 M ml Mo a Enterovirus, Clone 5-D8/1 M ml Mo a Hu Carcinoembryonic Antigen, Clone II-7 M ,2 ml Mo a Hu Carcinoembryonic Antigen, Clone II-7 M ml Mo a Hu Plasma Cell, Clone VS38c M ml Mo a Hu CD44, Phagocytic Glycoprotein-1, Clone DF1485 M ml Mo a Hu CD8, Clone C8/144B M ml Mo a Hu Follicular Dendritic Cell, Clone CNA.42 M ml Mo a Hu Hepatocyte, Clone OCH1E5 M ml Mo a Hu CD34 Class II, Clone QBEnd 10 M ,2 ml Mo a Hu CD34 Class II, Clone QBEnd 10 M ml Mo a Hu Topoisomerase IIα, Clone Ki-S1 M ml Mo a Hu Placental Alkaline Phosphatase, Clone 8A9 M ,2 ml Mo a Hu Placental Alkaline Phosphatase, Clone 8A9 M ml Mo a Hu CD246, ALK Protein, Clone ALK1 M ,2 ml Mo a Hu CD246, ALK Protein, Clone ALK1 M ml Mo a Hu Melan-A, Clone A103 M ,2 ml Mo a Hu Melan-A, Clone A103 M ,2 ml Mo a Hu p21waf1/cip1, Clone SX118 M ml Mo a Hu p27kip1, Clone SX53G8 M ml Mo a Hu BCL6 Protein, Clone PG-B6p M ,2 ml Mo a Hu BCL6 Protein, Clone PG-B6p M ml Mo a Hu CD138, Clone MI15 M ml Mo a Hu Granzyme B, Clone GrB-7 M ml Mo a Hu Cytokeratin 5/6, Clone D5/16 B4 M ,2 ml Mo a Hu Cytokeratin 5/6, Clone D5/16 B4 M ml Mo a Hu Epidermal Growth Factor Receptor (EGFR), Clone E30
5 M ml Mo a Hu Ki-67 Antigen, Clone MIB-1 M ,2 ml Mo a Hu Ki-67 Antigen, Clone MIB-1 M ml Mo a Hu Calretinin, Clone DAK-Calret 1 M ,2 ml Mo a Hu Calretinin, Clone DAK-Calret 1 M ml Mo a Rt Ki-67 Antigen, Clone MIB-5 M ml Mo a Hu CD3, F M ,2 ml Mo a Hu CD3, F M ml Mo a Hu CD7, CBC M ,2 ml Mo a Hu TPO, MoAb47 M ml Mo a Hu MUM1 Protein, Clone MUM1p M ,2 ml Mo a Hu MUM1 Protein, Clone MUM1p M ml Mo a Hu BCL 10 Protein, Clone 151 M ml Mo a Hu Laminin-5, Gamma-2 Chain, Clone 4G1 M ,2 ml Mo a Hu MCM3 Protein, Clone 101 M ,2 ml Mo a Hu HER2-pY-1248, Clone PN2A M ,2 ml Mo a Hu CD57, Clone TB01 M ,2 ml Mo a Hu Vascular Endothelial Growth Factor (VEGF), Clone VG1 M ,2 ml Monoclonal Mo a Hu LAT Protein, Clone LAT-1 M ml Monoclonal Mo a Hu Estrogen Receptor β1, Clone PPG5/10 M ,2 ml Monoclonal Mo a Hu Tissue Inhibitor of Metalloproteinases 1, Clone VT7 M ,2 ml Monoclonal Mo a Hu upar, Clone R4 M ,2 ml Monoclonal Mo a Hu CD19, Clone LE-CD19 M ,2 ml Monoclonal Mo a Hu HER3, Clone DAK-H3-IC M ,2 ml Monoclonal Mo a Hu Wild-Type EGFR, Clone DAK-H1-WT M ,2 ml Monoclonal Mo a Hu EGFR-pY-1197, Clone DAK-H1-pY-1197 M ,2 ml Monoclonal Mo a Hu Ribosomal Protein S6-pS240, Clone DAK-S6-240 M ml Monoclonal Mo a Hu ZAP-70, Clone 2F3.2 M ,2 ml Monoclonal Mo a Hu ZAP-70, Clone 2F3.2 M ml Monoclonal Mo a Hu CD56, Clone 123C3 M ,2 ml Monoclonal Mo a Hu CD56, Clone 123C3 M ml Monoclonal Mo a Hu Nucleophosmin, Clone 376 M ,2 ml Monoclonal Mo a Hu Nucleophosmin, Clone 376 M ml Monoclonal Mo a Hu BSAP, Clone DAK-Pax5 M ,2 ml Monoclonal Mo a Hu BSAP, Clone DAK-Pax5 M ml Monoclonal Mo a Hu CD10, Clone 56C6 M ,2 ml Monoclonal Mo a Hu CD10, Clone 56C6 M ml Monoclonal Mo a Hu CD2, Clone AB75 M ,2 ml Monoclonal Mo a Hu CD2, Clone AB75 M ml Monoclonal Mo a Hu CD4, Clone 4B12 M ,2 ml Monoclonal Mo a Hu CD4, Clone 4B12 M ml Monoclonal Mo a Hu CD23, Clone DAK-CD23 M ,2 ml Monoclonal Mo a Hu CD23, Clone DAK-CD23 M ml Monoclonal Mo a Hu MUC2, Clone CCP58 M ,2 ml Monoclonal Mo a Hu MUC2, Clone CCP58 M ml Monoclonal Rb a Hu ERG, Clone EP111 M ,2 ml Monoclonal Rb a Hu ERG, Clone EP111 M ml Monoclonal Mo a Hu Synaptophysin, Clone DAK-SYNAP M ,2 ml Monoclonal Mo a Hu Synaptophysin, Clone DAK-SYNAP M ml Monoclonal Mo a Hu MUC5AC, Clone CLH2 M ,2 ml Monoclonal Mo a Hu MUC5AC, Clone CLH2
6 M ml Monoclonal Mo a Hu p63, Clone DAK-p63 M ,2 ml Monoclonal Mo a Hu p63, Clone DAK-p63
NEU IM PROGRAMM. LOXO Antikörper für die Immunhistochemie (alphabetisch nach Bezeichnung sortiert) Art.Code Artikelbezeichnung Typ Einsatz Einheit
A20002 Actin, Alpha-Smooth Muscle; Clone 1A4 monoklonal IHC 2 ml Ready-to-use A00002.0025 Actin, Alpha-Smooth Muscle; Clone 1A4 monoklonal IHC 25 ml Ready-to-use A00002 Actin, Alpha-Smooth Muscle; Clone
Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
Schedule of ccreditation United Kingdom ccreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK University College London, operating UK NEQS for ccredited to UK NEQS ICC & ISH
CatalogNo Product Name Size
SIG-3250-1000 α-1-antichymotrypsin Polyclonal Antibody, Purified (SIGNET) SIG-3250-16 α-1-antichymotrypsin Polyclonal Antibody, Purified (SIGNET) L1 6mL SIG-3250-26 α-1-antichymotrypsin Polyclonal Antibody,
Ovarian tumors Ancillary methods
Ovarian tumors Ancillary methods Ovarian tumor course Oslo, 24-25/11/14 Prof. Ben Davidson, MD PhD Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway Division of
Index. F Factor VIII-related antigen, see VWF FactorXIIIa, for dermatofibroma, 272-275 5-HT, see Serotonin
A Acantholytic squamous cell carcinoma vs epithelioid angiosarcoma, 56-57 Acinic cell carcinoma of pancreas, 76-77 vs ductal adenocarcinoma, 74-75 vs islet cell tumor, 78-81 Adenomatoid tumor vs hemangioma,
Académie internationale de Pathologie - Division arabe XX ème congrès 24-26 novembre 2008 Alger. Immunohistochemistry in malignant mesotheliomas
Académie internationale de Pathologie - Division arabe XX ème congrès 24-26 novembre 2008 Alger Immunohistochemistry in malignant mesotheliomas Françoise Thivolet-Béjui Groupement Hospitalier Est Lyon-Bron
Practical Effusion Cytology
Practical Effusion Cytology A Community Pathologist s Approach to Immunocytochemistry in Body Fluid Cytology Emily E. Volk, MD William Beaumont Hospital Troy, MI College of American Pathologists 2004.
HKCPath Anatomical Pathology Peer Review and Scores : PDF version for download
AP2003R1 http://hkcpath.org. Correspondence: pkhui@ha.org.hk 1of 10 07/08/2003 HKCPath Anatomical Pathology Peer Review and Scores : PDF version for download AP141 Bone Marrow: Metastatic Carcinoma from
A23: Oncologic Disease- Tumor Markers
A23: Oncologic Disease- Tumor Markers Diagnosis Tumor Markers and Genetic Markers Use for Specific Malignancy The following information is from multiple guideline sources as recommendations for use of
Diagnosis of Mesothelioma Pitfalls and Practical Information
Diagnosis of Mesothelioma Pitfalls and Practical Information Mary Beth Beasley, M.D. Mt Sinai Medical Ctr Dept of Pathology One Gustave L Levy Place New York, NY 10029 (212) 241-5307 mbbeasleymd@yahoo.com
A Better Path for Cancer Diagnostics
INTERPRETATION FLEX Ready-to-Use Atlas of Stains - 4 th Edition A Better Path for Cancer Diagnostics Committed to raising the bar for higher quality During the last decades, organizations such as CAP,
Tumour Markers. What are Tumour Markers? How Are Tumour Markers Used?
Dr. Anthony C.H. YING What are? Tumour markers are substances that can be found in the body when cancer is present. They are usually found in the blood or urine. They can be products of cancer cells or
Immunohistochemistry (IHC) Outreach Services
Immunohistochemistry (IHC) Outreach Services Note t ype of fixative used if not neutral buffered f ormalin. Note t ype of tissue/specim en Unless specified otherwise, positive and negative controls react
Seattle. Case Presentations. Case 1. 76 year old female with a history of breast cancer 12 years ago. Now presents with a pleural effusion.
Seattle Montreal IAP September 2006 Case Presentations Allen M. Gown, M.D. Medical Director and Chief Pathologist PhenoPath Laboratories Clinical Professor of Pathology University of British Columbia Case
Immunohistochemistry of soft tissue tumors
Immunohistochemistry of soft tissue tumors Immunohistochemistry Major advances : antigen retrieval techniques (HIER) sensitive detection systems numerous antibodies of good quality Standardization : automated
Immunohistochemical differentiation of metastatic tumours
Immunohistochemical differentiation of metastatic tumours Dr Abi Wheal ST1. TERA 3/2/14 Key points from a review article written by Daisuke Nonaka Intro Metastatic disease is the initial presentation in
Immunohistochemistry on cytology specimens from pleural and peritoneal fluid
Immunohistochemistry on cytology specimens from pleural and peritoneal fluid Dr Naveena Singh Consultant Pathologist Bart health NHS Trust London United Kingdom Disclosures and Acknowledgements I have
Cleveland Clinic Laboratories
Cleveland Clinic Laboratories Anatomic Pathology Special Stains Group I for Microorganisms Special Stains Group I 88312 Fite stain Giemsa (h. pylori) Gomori s methenamine silver (GMS) Gram Gridley Steiner
Lessons from a consultation practice
Pitfalls in the Application of Immunohistochemistry in Diagnostic Pathology Lessons from a consultation practice Kevin O. Leslie, MD Professor and Consultant Mayo Clinic Arizona Scottsdale, Arizona Presenter
Immunohistochemistry in diagnostic pathology of tumors. Approach, benefits, limits and pitfalls
Aus dem Institut für Pathologie der Medizinischen Fakultät Charité Universitätsmedizin Berlin DISSERTATION Immunohistochemistry in diagnostic pathology of tumors. Approach, benefits, limits and pitfalls
Determination of the type and origin of metastatic
Diagnosis of Metastatic Neoplasms An Immunohistochemical Approach Murli Krishna, MD N Context. It is important to determine the type and/or site of origin of metastatic tumors for optimal clinical management.
Update on Mesothelioma
November 8, 2012 Update on Mesothelioma Intro incidence and nomenclature Update on Classification Diagnostic specimens Morphologic features Epithelioid Histology Biphasic Histology Immunohistochemical
MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY
MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo, Finland 2nd Nordic Conference on Applied
page antibody Adipophilin (polyclonal) ALDH1A1 (44) c-myc (EP121) * Cadherin-17 (SP183) Cathepsin K (3F9)
New IHC Antibodies 2 Table of Contents page antibody 1 2 3 4 5 6 7 8 Adipophilin (polyclonal) ALDH1A1 (44) c-myc (EP121) * Cadherin-17 (SP183) Cathepsin K (3F9) Caveolin-1 (2297) CD13 (SP187) CD16 (SP175)
Welcome to More Choice BD Analyte Specific Reagent (ASR) Catalog
Welcome to More Choice BD Analyte Specific Reagent (ASR) Catalog 3 rd Edition Contents ASR Cell Lineage 3 15 Marker 16 25 Flow cytometry allows you to analyze multiple parameters simultaneously and by
MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY
MALIGNANT MESOTHELIOMA CLASSIFICATION MALIGNANT MESOTHELIOMA UPDATE ON PATHOLOGY AND IMMUNOHISTOCHEMISTRY Sisko Anttila, MD, PhD Jorvi Hospital Laboratory of Pathology Helsinki University Hospital Espoo,
The term undifferentiated tumor has been used in reference
Undifferentiated Tumor True Identity by Immunohistochemistry Armita Bahrami, MD; Luan D. Truong, MD; Jae Y. Ro, MD, PhD Context. Undifferentiated tumor refers to a heterogeneous group of neoplasms with
Breast cancer and normal cell lines
The Essentials of Life Science Research Globally Delivered Breast cancer and normal cell lines ATCC No. Name Tissue Cell Type Disease Oganism Age Ethnicity Genes Expressed CRL-7227 Hs 281.T CRL-7245 Hs
Immunohistochemistry. Services & Products. Indivumed GmbH Falkenried 88, Bldg. D 20251 Hamburg Germany
Services & Products Indivumed GmbH Falkenried 88, Bldg. D 20251 Hamburg Germany Phone Europe: +49-40-41 33 83-0 Fax Europe: +49-40-41 33 83-14 Phone USA: +1-301-588-4650 info@indivumed.com www.indivumed.com
Laboratory examination in patients with tumours
Tumour markers Marta Kalousová Institute of Clinical Chemistry and Laboratory Diagnostics, 1 st Faculty of Medicine and General University Hospital, Charles University, Prague Laboratory examination in
How To Test For Cancer With A Blood Test
Histolab Products AB Eva Alströmer Jonas Falgén Helsingborg 7-8/10 2010 Table 1 Formalin Fixation Times and Estrogen Receptor Staining With 25 Minutes Antigen Retrieval Pretreatment Formalin Q-Score Difference
How To Test For Cancer
Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell! Effusion = Confusion Syed Z. Ali, M.D. Professor of Pathology and Radiology The Johns Hopkins Hospital Baltimore, Maryland Diagnostic
Cleveland Clinic Laboratories
Cleveland Clinic Laboratories Anatomic Pathology Special Stains Group I for Microorganisms Special Stains Group I 88312 Fite stain Gomori s methenamine silver (GMS) Gram Gridley PAS/light green counterstain
DAKO OEM. Product Catalog
DAKO OEM Product Catalog 2 PRODUCT CATALOG DAKO OEM LASTING PARTNERSHIPS SCIENTIFIC ADVANCEMENT CERTAINTY Dako An Introduction Established in 1966, Dako has played a pioneering role in the standardization
Case of the. Month October, 2012
Case of the Month October, 2012 Case The patient is a 47-year-old male with a 3-week history of abdominal pain. A CT scan of the abdomen revealed a suggestion of wall thickening at the tip of the appendix
Disclosures. Learning Objectives. Effusion = Confusion. Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell!
Disclosures Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell! No Relevant Financial Relationships with Commercial Interests Syed Z. Ali, M.D. Syed Z. Ali, M.D. Associate Professor of
P R O D U C T S CATALOG 2011-2012
P R O D U C T S CATALOG 2011-2012 INSTITUTE FOR THE APPLICATION OF NUCLEAR ENERGY - INEP Banatska 31b 11080 Zemun Belgrade Serbia Tel: (+381 11) 2619 252, 2618 696, 2199 949 Fax: (+381 11) 2618 724 www.inep.co.rs
The develpemental origin of mesothelium
Mesothelioma Tallinn 14.12.06 Henrik Wolff Finnish Institute of Occupational Health The develpemental origin of mesothelium Mesodermal cavities (pleura, peritoneum and pericardium ) are lined with mesenchymal
Hormones: Classification. Hormones: Classification. Peptide Hormone Synthesis, Packaging, and Release
Hormones: Classification Hormones: Classification Be able to give types and example. Compare synthesis, half-life and location of receptor 1. Peptide or protein hormones Insulin from amino acids 2. Steroid
Colon cancer and normal cell lines
The Essentials of Life Science Research Globally Delivered Colon cancer and normal cell lines ATCC No. Name Tissue Cell Type Disease Oganism Age Ethnicity Genes Expressed CRL-2577 RKO Carcinoma CRL-2579
Applications of immunohistology to non-heme tumor differential diagnosis R V Rouse 7/22/2014 http://surgpathcriteria.stanford.edu
Applications of immunohistology to non-heme tumor differential diagnosis R V Rouse 7/22/2014 http://surgpathcriteria.stanford.edu Table of Contents Page Undifferentiated panel 1 CK7/20 table 2 Breast carcinoma
Articles. Nordic Immunohistochemical Quality Control (NordiQC) - An Organization for External Quality Assurance. Mogens Vyberg, MD
Articles Nordic Immunohistochemical Quality Control (NordiQC) - An Organization for External Quality Assurance Mogens Vyberg, MD Institute of Pathology. Aalborg Hospital Aarhus University Hospital Denmark
PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet
PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry M. Praet Pathology of the Pleura Normal serosa: visceral and parietal layers Inflammation Neoplasia: Primary: mesothelioma
B Cells and Antibodies
B Cells and Antibodies Andrew Lichtman, MD PhD Brigham and Women's Hospital Harvard Medical School Lecture outline Functions of antibodies B cell activation; the role of helper T cells in antibody production
Emerging Subtypes in Renal Cancer. Donna E. Hansel, MD PhD Professor of Pathology, UC San Diego Division Chief, Anatomic Pathology dhansel@ucsd.
Emerging Subtypes in Renal Cancer Donna E. Hansel, MD PhD Professor of Pathology, UC San Diego Division Chief, Anatomic Pathology dhansel@ucsd.edu Some General Comments Fuhrman nuclear grading clear cell
Effusions: Mesothelioma and Metastatic Cancers
Effusions: Mesothelioma and Metastatic Cancers Malignant Mesothelioma Incidence: 2,500 cases/year ~60-80% pts with pleural MM relationship with asbestos exposure Other risk factors: radiation, other carcinogens,
PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT
PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT Dott. Francesco Pontieri (*) U.O. di Anatomia Patologica P.O. di Rossano (CS) Dott. Gian Franco Zannoni Anatomia Patologica Facoltà di Medicina e Chirurgia
Immunohistochemistry of clear cell tumours. What are clear cell tumours? Jan Klos 1
Immunohistochemistry of clear cell tumours J. Klos MD Department of Pathology Stavanger University Hospital Norway What are clear cell tumours? Multiple factors in etiology of clear cell changes: - technical
A 70-year old Man with Pleural Effusion
Mesothelioma Diagnosis: Pitfalls and Latest Updates S Klebe and DW Henderson Recommendations Indisputable malignant cells on cytomorphological criteria which demonstrate a mesothelial phenotype, which
Outline. Workup for metastatic breast cancer. Metastatic breast cancer
Metastatic breast cancer Immunostain Update: Diagnosis of metastatic breast carcinoma, emphasizing distinction from GYN primary 1/3 of breast cancer patients will show metastasis 1 st presentation or 20-30
Activation and effector functions of HMI
Activation and effector functions of HMI Hathairat Thananchai, DPhil Department of Microbiology Faculty of Medicine Chiang Mai University 25 August 2015 ว ตถ ประสงค หล งจากช วโมงบรรยายน แล วน กศ กษาสามารถ
Immunohistochemical classification of the unknown primary tumour
Immunohistochemical classification of the unknown primary tumour NordiQC Workshop 2014 Prof. Mogens Vyberg Institute of Pathology Aalborg, Denmark PART 2 Secondary panels for carcinoma identification/subclassification
Cytokeratins and generel epithelial markers in tumour classification
Cytokeratins and generel epithelial markers in tumour classification 42, liver adenocarcinoma of unknown primary Colonrectum? Pancreas/biliary tract? Stomach? Lung? Ovary/endometrium? Mogens Vyberg, NordiQC
immunohistochemistry stain offerings
immunohistochemistry stain offerings TRUSTED PATHOLOGISTS. INVALUABLE ANSWERS. www.aruplab.com/ap-ihc JULY 2015 Information in this brochure is current as of July 2015. All content is subject to change.
Immunohistochemical classification of malignant lymphomas
Immunohistochemical classification of malignant lymphomas Prof. Mogens Vyberg NordiQC Institute of Pathology Aalborg, Denmark Thanks to Jan Klos Important issues Distinction from non-hematopoietic neoplasms
Victims Compensation Claim Status of All Pending Claims and Claims Decided Within the Last Three Years
Claim#:021914-174 Initials: J.T. Last4SSN: 6996 DOB: 5/3/1970 Crime Date: 4/30/2013 Status: Claim is currently under review. Decision expected within 7 days Claim#:041715-334 Initials: M.S. Last4SSN: 2957
Bone cancer and normal cell lines
The Essentials of Life Science Research Globally Delivered Bone cancer and normal cell lines ATCC No. Name Tissue Cell Type Disease Oganism Age Ethnicity Genes Expressed CRL-1873 RS4;11 marrow lymphoblast
I n f o r m a t i o n
I n f o r m a t i o n L I N A R I S ACE2 Purified Polyclonal Rabbit PS*,WB, 0,1 mg LAH0888 Actin Purified ACTB19 Mouse IgG2a EIA,IF,PS,WB, 0,1 mg ADI-ACTB19-M Actin Purified, S/N, Concentrate HHF35 Mouse
Tumor Patterns. Common Morphologic Patterns in Soft Tissue Tumors. Update on Lipomatous Tumors. MFH-like. Highly cellular spindle cell pattern
Common Morphologic Patterns in Soft Tissue Tumors John R. Goldblum, M.D. Chairman, Department of Anatomic Pathology The Cleveland Clinic Professor of Pathology Cleveland Clinic Lerner College of Medicine
VPM 152. INFLAMMATION: Chemical Mediators
General Pathology VPM 152 INFLAMMATION: Chemical Mediators CHEMICAL MEDIATORS OF INFLAMMATION Definition: any messenger that acts on blood vessels, inflammatory cells or other cells to contribute to an
Understanding series. new. directions. 1-800-298-2436 LungCancerAlliance.org. A guide for the patient
Understanding series LUNG CANCER: new treatment directions 1-800-298-2436 LungCancerAlliance.org A guide for the patient TABLE OF CONTENTS What s New in lung cancer? Advancements...4 Changes in genes that
JOURNAL OF CLINICAL ONCOLOGY DIAGNOSIS IN ONCOLOGY
VOLUME 28 NUMER 34 DECEMER 1 2010 JOURNL OF CLINICL ONCOLOGY DIGNOSIS IN ONCOLOGY Renal Cell Carcinoma With t(6;11) Translocation: Patient Case With a Novel lpha- Fusion Point Renal cell carcinoma (RCC)
Editorial. John Hicks Department of Pathology, Texas Children s Hospital and Baylor College of Medicine, Houston, Texas, USA
3b2 Version Number : 7.51c/W (Jun 11 2001) File path : p:/santype/journals/taylor&francis/uusp/v30n1-2/uusp131296/uusp131296.3d Date and Time : 22/2/06 and 19:36 Ultrastructural Pathology, 30:1 2, 2006
Case based applications part III
Case based applications part III Los Angeles Society Of Pathologists January 25, 2014 Sanja Dacic, MD, PhD University of Pittsburgh Medical Center 1 CASE 1 A 44-year-old woman with multiple lung nodules.
20 Diagnostic Cytopathology, Vol 36, No 1 ' 2007 WILEY-LISS, INC.
Utility of WT-1, p63, MOC31, Mesothelin, and Cytokeratin (K903 and CK5/6) Immunostains in Differentiating Adenocarcinoma, Squamous Cell Carcinoma, and Malignant Mesothelioma in Effusions Robert T. Pu,
Name (print) Name (signature) Period. (Total 30 points)
AP Biology Worksheet Chapter 43 The Immune System Lambdin April 4, 2011 Due Date: Thurs. April 7, 2011 You may use the following: Text Notes Power point Internet One other person in class "On my honor,
KMS-Specialist & Customized Biosimilar Service
KMS-Specialist & Customized Biosimilar Service 1. Polyclonal Antibody Development Service KMS offering a variety of Polyclonal Antibody Services to fit your research and production needs. we develop polyclonal
Anatomic Pathology / PERITONEAL MESOTHELIOMA AND SEROUS CARCINOMA
Anatomic Pathology / PERITONEAL MESOTHELIOMA AND SEROUS CARCINOMA Immunohistochemical Analysis of Peritoneal Mesothelioma and Primary and Secondary Serous Carcinoma of the Peritoneum Antibodies to Estrogen
Recombinant Antibody Fragments, Brochure
Recombinant Antibody Fragments, Brochure Interest in any of the products, request or order them at Bio-Connect Diagnostics. Bio-Connect Diagnostics B.. T NL +31 (0)26 326 44 60 T BE +32 (0)2 502 12 53
Diagnostic Challenge. Department of Pathology,
Cytology of Pleural Fluid as a Diagnostic Challenge Paavo Pääkkö,, MD, PhD Chief Physician and Head of the Department Department of Pathology, Oulu University Hospital,, Finland Oulu University Hospital
Developments in Biomarker Identification and Validation for Lung Cancer
Developments in Biomarker Identification and Validation for Lung Cancer Alexandre Passioukov, MD, PhD Alexandre.Passioukov@eortc.be Contents Introduction Lung cancer pathogenesis NSCLC treatment options
ANTICUERPOS PARA INMUNOHISTOQUÍMICA 2015
ACTH (HORMONA ADRENOCORTICOTROPA) 56 ACTH(HORMONA ADRENOCORTICOTROPA) ACTINA MUSCULAR GENÉRICA HHF35 ACTINA MÚSCULO LISO 1A4 ACTINA MUSCULOESQUELÉTICA 5C5,F8,C7 ALFA-1-ANTIQUIMIOTRIPSINA ALFA-1-ANTITRIPSINA
What is New in Oncology. Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals
What is New in Oncology Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals Personalized Medicine Personalized Genomics Genomic Medicine Precision Medicine Definition Application
Cytology of Effusion Fluids. Cytology of Effusion Fluids. Types of Effusion Fluids. Anatomy. Causes of Effusions. Sampling of Effusion Fluids
Cytology of Effusion Fluids John W. Wong, MD, FRCPC Sunnybrook Health Sciences Centre Assistant Professor, Laboratory Medicine and Pathobiology Faculty of Medicine, University of Toronto November 10, 2012
The Immune System: A Tutorial
The Immune System: A Tutorial Modeling and Simulation of Biological Systems 21-366B Shlomo Ta asan Images taken from http://rex.nci.nih.gov/behindthenews/uis/uisframe.htm http://copewithcytokines.de/ The
Epithelial Tumors of the Kidney Diagnostic Problems and Recently Described Entities
Pathology of Renal Neoplasia Epithelial Tumors of the Kidney Diagnostic Problems and Recently Described Entities Wael A Sakr, MD Wayne State University School of Medicine CURRENT CLASSIFICATION = EPITHELIAL
CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY
CASE OF THE MONTH AUGUST-2015 DR. GURUDUTT GUPTA HEAD HISTOPATHOLOGY CASE HISTORY 52Y MALE RIGHT RADICAL NEPHERECTOMY Case of right renal mass with IVC thrombus. History of surgery and RT for right occipital
How To Get A Cell Print
QUICK CELL CAPTURE AND CHARACTERIZATION GUIDE FOR CELLSEARCH CUSTOMERS CellSave EDTA Blood sample Rare cell capture Enumeration Single protein marker Cell capture for molecular characterization CELLSEARCH
Antibody Cross-Reactivity Chart
Page 1 of 6 CD2 RPA-2.10 Human Chimpanzee, Baboon, Cynomolgus, Rhesus, Pigtailed Macaque, Capuchin Monkey, Swine (Pig, Porcine) CD3 SK7 Human Chimpanzee CD3 UCHT1 Human Chimpanzee CD4 OKT4 Human Chimpanzee,
Breast cancer or metastasis? An unusual case of metastatic malignant pleural mesothelioma to the breast
Framarino-dei-Malatesta et al. World Journal of Surgical Oncology (2015) 13:79 DOI 10.1186/s12957-015-0491-z WORLD JOURNAL OF SURGICAL ONCOLOGY CASE REPORT Open Access Breast cancer or metastasis? An unusual
The Value of Thyroid Transcription Factor-1 in Cytologic Preparations as a Marker for Metastatic Adenocarcinoma of Lung Origin
Anatomic Pathology / TTF-1 IN CYTOLOGY OF BODY FLUIDS The Value of Thyroid Transcription Factor-1 in Cytologic Preparations as a Marker for Metastatic Adenocarcinoma of Lung Origin Jonathan L. Hecht, MD,
Problem Cases in Surgical Pathology XXV Congreso de la Sociedad Española de Patologia (SEAP) - Zaragoza, Mayo 18-21, 2011.
Problem Cases in Surgical Pathology XXV Congreso de la Sociedad Española de Patologia (SEAP) - Zaragoza, Mayo 18-21, 2011. Saul Suster, M.D. Medical College of Wisconsin Milwaukee, WI, USA Case - 2 Clinical
RENAL CELL CARCINOMA EPIDEMIOLOGY
RENAL CELL CARCINOMA: THE 2012 ISUP VANCOUVER CLASSIFICATION David Grignon MD, Indiana University, Indianapolis, IN RENAL CELL CARCINOMA EPIDEMIOLOGY Siegel et al. CaA Cancer J Clin 63:11-30, 2013 1 EPITHELIAL
Describe how these hormones exert control quickly by changes in phosphorylation state of enzyme, and more slowly by changes of gene expression
Section VIII. Section VIII. Tissue metabolism Many tissues carry out specialized functions: Ch. 43 look at different hormones affect metabolism of fuels, especially counter-insulin Ch. 44 Proteins and
Clinicopathological Study on Malignant Pleural Mesotheliomas
Table of Contents Clinicopathological Study on Malignant Pleural Mesotheliomas PL-4-03 Kenzo Hiroshima Kenzo Hiroshima 1, Akira Iyota 1, Kiyoshi Sibuya 1, Toshikazu Yusa 2, Takehiko Fujisawa 1 and Yukio
targeted therapy a guide for the patient
targeted therapy FOR LUNG CANCER a guide for the patient TABLE OF CONTENTS lung cancer basics... 2-3 Gene changes... 4-5 Testing... 7-8 Targeted therapy... 9-11 Drugs Targeting EGFR... 12 Drugs Targeting
NEOPLASIA (4) Tumor-Host Interactions and Systemic Effects of Neoplasms
NEOPLASIA (4) Tumor-Host Interactions and Systemic Effects of Neoplasms Rex Bentley, M.D. Department of Pathology M216A, Duke South Green Zone Rex.Bentley@duke.edu 684-6423 NEOPLASIA (IV) Goals and Objectives
Chapter 43: The Immune System
Name Period Our students consider this chapter to be a particularly challenging and important one. Expect to work your way slowly through the first three concepts. Take particular care with Concepts 43.2
Product Datasheet and Instructions for Use
Product Code: MP-378-CMK01 (0.1ml conc) MP-378-CMK05 (0.5ml conc) MP-378-PM6 (6ml RTU) Product Description: CD141 (Thrombomodulin) Concentrated and Prediluted Monoclonal Antibody Control Number: 901-378-071709
Cell Stimulation Cocktail (plus protein transport inhibitors) (500X) 00 4975 03 x 100 ul ebioscience Bender 4x100 µl Ab pab 419 356,15
Codice NomeProdotto Azienda Conf. Tipologia p Tipo Ab Clone numbprezzo ListiPrezzo Scontato Sconto: 15 00 0044 59 ELISA/ELISPOT Coating Buffer Powder ea ebioscience Bender 1 Pz Reag.Tamponi 59 50,15 00
Excellent FFPE. Staining
Outstanding Markers Excellent FFPE Staining Superior Staining Quality High Titer Best Price O P T I S TA I N Anti-PD-1 (clone NAT105) - a marker for follicular helper T cells (T FH ) and T-cell lymphomas
Immunohistochemistry in the Diagnosis of Metastatic Carcinoma of Unknown Primary Origin
Immunohistochemistry in the Diagnosis of Metastatic Carcinoma of Unknown Primary Origin Rodney T. Miller, M.D. Director of Immunohistochemistry ProPath Laboratory 1355 River Bend Drive Dallas, TX 75247-4915
Ch16 Endocrine part 2
Ch16 Endocrine part 2 several separate organs release hormones into capillaries hormones are transported in the blood Hypothalamus Pituitary glands Pineal gland Thyroid Parathyroid Thymus Adrenal Cortex
Amplification Products for PCR and RT-PCR
Panel A : Green dye D.36 Panel B : Regular PCR Human IL-18 gene derived fron Spleen cdna was analyzed by two-step RT-PCR using PCR Primer of T63710 (Lane 1-7 : 5 fold series dilution, cdna from 100 ng
Smooth Muscle. Learning Objectives.
Smooth Muscle. Learning Objectives. At the end of this course, you should be able to : 1. describe the structure of smooth muscle 2. describe where smooth muscle occurs within the body 3. discuss the structural
Mechanism of hormone action
Mechanism of hormone action ผศ.ดร.พญ.ส ว ฒณ ค ปต ว ฒ ภาคว ชาสร รว ทยา คณะแพทยศาสตร ศ ร ราชพยาบาล Aims What is hormone receptor Type of hormone receptors - cell surface receptor - intracellular receptor
Immunoassay. Product Portfolio. www.diametra.com info@diametra.com Part of the IDS group
Immunoassay Portfolio www.diametra.com info@diametra.com Part of the IDS group Bringing Value-Added Efficiency To Your Laboratory Diametra is dedicated to providing quality products and the highest level
DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE
DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE Ryan Granger University of Rhode Island Cytotechnology program May 2, 2015 ASCT Annual Meeting Nashville, Tennessee DESMOPLASTIC SMALL ROUND
Natalia Taborda Vanegas. Doc. Sci. Student Immunovirology Group Universidad de Antioquia
Pathogenesis of Dengue Natalia Taborda Vanegas Doc. Sci. Student Immunovirology Group Universidad de Antioquia Infection process Epidermis keratinocytes Dermis Archives of Medical Research 36 (2005) 425
MALIGNANT MESOTHELIOMA: A TYPICAL PRESENTATION IN AN ATYPICAL PATIENT
MALIGNANT MESOTHELIOMA: A TYPICAL PRESENTATION IN AN ATYPICAL PATIENT Written by: Karyn Varley MS, SCT(ASCP) The donating laboratory would like to remain anonymous. PATIENT HISTORY 28 year old female Lived